Home>

Products

Submit Request Quote
 * Denotes Required Field.
Name:
 *
Company Name:
Phone:
Email:
 *
Message:
Request Quote
 
Out Of Stock image

Is currently out of stock, however if you enter your email address we will notify you when it comes back into stock!

Continue shopping Get Notified

Anti-CD4 [CD4R1]

Anti-CD4 [CD4R1]
Product Type: Therapeutics (In Vivo)
Format: Anti-CD4, CD4R1 (OKT4A), rhesusized variable region, rhesus IgG
Clone ID: [CD4R1]
RRID: AB_2716322
Common Names: Anti-CD4 [CD4R1] | Depleting anti-CD4 (rhesus recombinant) | OKT4A | PR-0407 | NHP11 | aCD4_OKT4A_rz_G1k_mamu
Target: CD4
Reactivity: Human (Homo sapiens) Rhesus Macaque (Macaca mulatta)
Applications: in vivo; depletion
Description:

CD4R1: Rhesus recombinant, CDR-grafted anti-CD4 IgG1-kappa antibody. Derived from OKT4A.

 

How to cite this reagent

For your Materials & Methods section:

The rhesus IgG1 recombinant Anti-CD4 [CD4R1] monoclonal antibody was engineered and produced by the Nonhuman Primate Reagent Resource (NIH Nonhuman Primate Reagent Resource Cat# PR-0407, RRID:AB_2716322)

For your Acknowledgements  section:

"The Anti-CD4 [CD4R1] antibody used in this study was provided by the NIH Nonhuman Primate Reagent Resource (P40 OD028116)".
Modifications: None
Restrictions: No
Sponsor: ORIP

Reagent cost, which is the actual cost of production, is recovered for some reagents. Please inquire if you have questions about reagent cost recovery. Purchase order or credit card is NOW REQUIRED for cost-recovered reagents.

You are not authorized to purchase this product. Please ensure you are logged into your account.

CAN'T FIND EXACTLY WHAT YOUR RESEARCH REQUIRES?

Request a Reagent:

Would you like to see an NHP-specific antibody developed through the program? Suggest a new reagent that would benefit the NHP community.

REQUEST A REAGENT

The Nonhuman Primate Reagent Resource (NHPRR) is a nonprofit laboratory established in 1999, and supported by the National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), and Office of Research Infrastructure Programs (ORIP).

Copyright © 2004-2023